HR Combined With FOLFOX4 for HCC With PVTT
NCT02452853
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE:
HR
DRUG:
FOLFOX4
Sponsor
Sun Yat-sen University